Abstract
A change in the lipoprotein profile is a metabolic hallmark of aging and has been the target for modern medical developments. Although pharmaceutical interventions aimed at lipid lowering substantially decrease the risk of cardiovascular disease, they have much less impact on mortality and longevity. Moreover, they have not affected death from other age-related diseases. In this review we focus on high density lipoprotein (HDL) cholesterol, the levels of which are either elevated or do not decrease as would be expected with aging in centenarians, and which are associated with lower prevalence of numerous age-related diseases; thereby, suggesting a potential HDL-mediated mechanism for extended survival. We also provide an update on the progress of identifying longevity-mediating lipid genes, describe approaches to discover longevity genes, and discuss possible limitations. Implicating lipid genes in exceptional longevity may lead to drug therapies that prevent several age-related diseases, with such efforts already on the way.
Current Vascular Pharmacology
Title:Phenotypes and Genotypes of High Density Lipoprotein Cholesterol in Exceptional Longevity
Volume: 12 Issue: 5
Author(s): Sofiya Milman, Gil Atzmon, Jill Crandall and Nir Barzilai
Affiliation:
Keywords: Aging, APOC3, CETP, genetics, HDL, longevity.
Abstract: A change in the lipoprotein profile is a metabolic hallmark of aging and has been the target for modern medical developments. Although pharmaceutical interventions aimed at lipid lowering substantially decrease the risk of cardiovascular disease, they have much less impact on mortality and longevity. Moreover, they have not affected death from other age-related diseases. In this review we focus on high density lipoprotein (HDL) cholesterol, the levels of which are either elevated or do not decrease as would be expected with aging in centenarians, and which are associated with lower prevalence of numerous age-related diseases; thereby, suggesting a potential HDL-mediated mechanism for extended survival. We also provide an update on the progress of identifying longevity-mediating lipid genes, describe approaches to discover longevity genes, and discuss possible limitations. Implicating lipid genes in exceptional longevity may lead to drug therapies that prevent several age-related diseases, with such efforts already on the way.
Export Options
About this article
Cite this article as:
Milman Sofiya, Atzmon Gil, Crandall Jill and Barzilai Nir, Phenotypes and Genotypes of High Density Lipoprotein Cholesterol in Exceptional Longevity, Current Vascular Pharmacology 2014; 12 (5) . https://dx.doi.org/10.2174/1570161111666131219101551
DOI https://dx.doi.org/10.2174/1570161111666131219101551 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
An Overview of Currently Available Antimalarials
Current Topics in Medicinal Chemistry Cardiovascular Effects of Omega-3 Free Fatty Acids.
Current Vascular Pharmacology Impact of Pre-Diabetes and Diabetes on Cardiovascular Outcomes
Current Vascular Pharmacology Preconditioned Stem Cells: A Promising Strategy for Cell-Based Ischemic Stroke Therapy
Current Drug Targets How to Investigate the Vascular Changes in Resistant Hypertension
Current Hypertension Reviews Inflammation in Coronary Artery Disease and Acute Myocardial Infarction - is the Stage Set for Novel Therapies?
Current Pharmaceutical Design Graphical Abstracts:
Recent Patents on Drug Delivery & Formulation Editorial [ NeuroAIDS: A Neuroscience Problem with Global Impact ]
Current HIV Research The Biphasic Virulence Activities of Gingipains: Activation and Inactivation of Host Proteins
Current Protein & Peptide Science ACKNOWLEDGEMENTS TO REVIEWERS
Current Hypertension Reviews Olfactory Dysfunction and Cognitive Impairment in Age-Related Neurodegeneration: Prevalence Related to Patient Selection, Diagnostic Criteria and Therapeutic Treatment of Aged Clients Receiving Clinical Neurology and Community-Based Care
Current Clinical Pharmacology Vascular Adenosine Receptors; Potential Clinical Applications
Current Vascular Pharmacology Editorial [Hot topic: Current Status of Drug Eluting Stents (Executive Editor: Nicholas Kipshidze)]
Current Pharmaceutical Design Chirality - A New Era of Therapeutics
Mini-Reviews in Medicinal Chemistry Gene Profiles within the Adult Subventricular Zone Niche:Proliferation, Differentiation and Migration of Neural Progenitor Cells in the Ischemic Brain
Current Molecular Medicine Psychological Stress and the Development of Heart Disease
Current Psychiatry Reviews Development and Validation of a Reliable LC-MS/MS Method for Simultaneous Quantification of Hydrochlorothiazide in the Presence of Different Co-formulated Anti-hypertensive Medications in Biological Matrix
Current Pharmaceutical Analysis Patent Selections:
Recent Patents on Cardiovascular Drug Discovery Prediction of Thrombin and Factor Xa Inhibitory Activity with Associative Neural Networks
Current Computer-Aided Drug Design Quality Based Design Approach for Improving Oral Bioavailability of Valsartan Loaded Smedds And Study of Impact of Lipolysis on the Drug Diffusion
Drug Delivery Letters